65--NOTICE OF INTENT TO ISSUE A SOLE SOURCE PURCHASE ORDER

The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of U.S. Army Medical Material Development Activity (USAMMDA) intends to issue a firm fixed price purchase order for 150 vials of Ribavirin. USAMRAA intends to negotiate this contract on a sole source basis with Valeant Pharmaceuticals International, Aliso Viejo, CA, in accordance with Federal Acquisition Regulation (FAR) Part 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. This product is a FDA Investigational New Drug (IND) sponsored by the U.S. Army Office of the Surgeon General. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. If no written responses are received at least fifteen (15) days after the publication of this response, the purchase will be awarded without further notice. The Point of Contact for this action is [email protected].